These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 11918623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A variant of paraoxonase (PON1) gene is associated with diabetic retinopathy in IDDM.
    Kao YL, Donaghue K, Chan A, Knight J, Silink M.
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2589-92. PubMed ID: 9661650
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene.
    Pan JP, Lai ST, Chiang SC, Chou SC, Chiang AN.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):415-21. PubMed ID: 12433026
    [Abstract] [Full Text] [Related]

  • 9. Paraoxonase 1 Gln/Arg polymorphism is associated with the risk of microangiopathy in Type 2 diabetes mellitus.
    Murata M, Maruyama T, Suzuki Y, Saruta T, Ikeda Y.
    Diabet Med; 2004 Aug; 21(8):837-44. PubMed ID: 15270786
    [Abstract] [Full Text] [Related]

  • 10. Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes.
    Fekih O, Triki S, Rejeb J, Neffati F, Douki W, Ommezzine A, Chouchane S, Guediche MN, Bouslama A, Najjar MF.
    Endokrynol Pol; 2017 Aug; 68(1):35-41. PubMed ID: 26884296
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.
    Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler A, Page G, Brown WV, Lyons TJ, Garvey WT, DCCT/EDIC Research Group.
    J Diabetes Complications; 2005 Aug; 19(1):18-25. PubMed ID: 15642486
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [A search for association between the polymorphic markers of PON1 and PON2 genes and diabetic nephropathy in patients with type I diabetes mellitus].
    Voron'ko OE, Iakunina NIu, Shestakova MV, Zotova EV, Chugunova EV, Shamkhalova MSh, Vikulova OK, Debabov VG, Dedov VG, Nosikov VV.
    Genetika; 2005 Jun; 41(6):844-9. PubMed ID: 16080611
    [Abstract] [Full Text] [Related]

  • 17. Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients.
    James RW, Leviev I, Ruiz J, Passa P, Froguel P, Garin MC.
    Diabetes; 2000 Aug; 49(8):1390-3. PubMed ID: 10923642
    [Abstract] [Full Text] [Related]

  • 18. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
    Chi DS, Ling WH, Ma J, Xia M, Hou MJ, Wang Q, Zhu HL, Tang ZH, Yu XP.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
    [Abstract] [Full Text] [Related]

  • 19. Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.
    Bansal S, Chawla D, Banerjee BD, Madhu SV, Tripathi AK.
    Gene; 2013 Sep 10; 526(2):325-30. PubMed ID: 23721855
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.